332 followers
RT @NatureMedicine: Second-line treatment with axi-cel (anti-CD19 #CARTcells) resulted in high response rates and durable remissions in pat…
RT @NatureMedicine: Second-line treatment with axi-cel (anti-CD19 #CARTcells) resulted in high response rates and durable remissions in pat…
HAEM: in a study of patients with relapsed DLBCL requiring second line therapy but ineligible for autologous stem cell transplantation, CD19 CAR T (axi-cel) delivered 71% complete metabolic response at 3 months without unexpected toxicity. https://t.co/…
RT @RemyDulery: ✨New in @NatureMedicine! 2nd line treatment with axi-cel #CARTcells resulted in high response rates and durable remissions…
RT @RemyDulery: ✨New in @NatureMedicine! 2nd line treatment with axi-cel #CARTcells resulted in high response rates and durable remissions…